Skip to main content
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. — Investor Relations & Filings

Ticker · BNTC ISIN · US08205P2092 US Manufacturing
Filings indexed 290 across all filing types
Latest filing 2026-03-20 Annual Report
Country US United States of America
Listing US BNTC

About Benitec Biopharma Inc.

https://benitec.com/

Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development of novel genetic medicines. The company utilizes its proprietary DNA-Directed RNA Interference (ddRNAi) platform, which combines gene therapy with RNA interference (gene silencing) to create treatments. This technology is designed to permanently silence disease-causing genes. Benitec's therapeutic programs target chronic and life-threatening human diseases that are gene-associated and for which there are currently no effective treatments or cures.

Recent filings

Filing Released Lang Actions
10-K/A - Benitec Biopharma Inc. (0001808898) (Filer)
Annual Report FY 2025
2026-03-20 English
10-Q Filing
Interim / Quarterly Report Q2 2026
2026-02-12 English
8-K Filing
Regulatory Filings
2026-02-12 English
S-3 Filing
Registration Form
2026-01-30 English
4 Filing
Director's Dealing
2026-01-26 English
Director's Dealing 2025
Director's Dealing
2025-12-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.